Menlo Park, California, 94025, United States
NCT Number: NCT00821002
A Phase 2 Study of Punctal Placement of the Latanoprost Punctal Plug Delivery System (L-PPDS)
The study objective is to compare IOP and safety outcomes based on plug placement (upper or lower puncta).
Looking for future studies?
Notify MeKey information
Age range
18 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 2
Primary location
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Over 18 years
- Diagnosed with bilateral Open-Angle Glaucoma or Ocular Hypertension
Exclusion criteria
- Uncontrolled medical conditions
- Subjects who wear contact lenses
- Subjects requiring chronic topical artificial tears, lubricants, and /or requiring any other chronic topical medications
Treatment and study plan
latanoprost
DrugComparison of punctal plug placement between upper and lower puncta
Primary outcomes
-
Intraocular pressure change from baseline (mmHg)
Time frame: 6 weeks
Secondary outcomes
-
Number of subjects with adverse events
Time frame: 6 weeks
Sponsors and collaborators
Lead sponsor
Mati Therapeutics Inc.
Industry
Collaborators
- QLT Inc.
Registry information
Official study title
An Open-Label, Phase 2 Study of Punctal Placement of the Latanoprost Punctal Plug System (L-PPDS) in Subjects With Ocular Hypertension (OH) or Open-Angle Glaucoma (OAG)
Important dates
- Study start
- 2009
- Primary completion
- 2009
- Study completion
- 2009
- First posted
- Jan 12, 2009
- Registry last updated
- Sep 19, 2013
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
A Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months
NCT01699464
Eye Diseases, Glaucoma
View Trial DetailsA Study Demonstrating The Effect Of Latanoprost In Combination With Timolol, Latanoprost Alone And Timolol Alone On Eye Pressure In Open Angle Glaucoma Or Ocular Hypertension In Patients
NCT00856622
Eye Diseases, Glaucoma
Aachen, Germany
View Trial DetailsA Three Part Study of MGV354 in Ocular Hypertension or Glaucoma
NCT02743780
Eye Diseases, Glaucoma
View Trial DetailsMulti-center Phase II Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
NCT02179008
Eye Diseases, Glaucoma
Chandler, Arizona, United States
View Trial Details